• About ExonHit
  • Diagnostics
  • Therapeutics
  • Technology
  • Investors
  • News Center
  •  
  •  

ExonHit is a fast emerging healthcare player active in both therapeutics and diagnostics. ExonHit is based in Paris, France, and has US offices in Gaithersburg, Maryland. The Company employs 65 associates.

Home

Navigation

  • About ExonHit
    • Overview
    • History
    • Management Board
      • Loïc Maurel M.D.
      • Hervé Duchesne de Lamotte
      • Matthew Pando Ph.D
    • Supervisory Board
      • Laurent Condomine
      • Patrick Langlois
      • Christophe Jean
      • Deborah Smeltzer
      • Frederic Desdouits
      • Michel Picot
    • Scientific Advisory Board
      • Pierre Chambon
      • Dominique Stehelin
      • Edwin Milgrom
      • Gustavo C. Roman
      • Pascale Briand
      • Pierre Corvol
    • Join Us
    • Locations

Languages

  • English
  • Français

Print

  • CLICK HERE TO PRINT

Contact us

Send this article
 


 
Home » About ExonHit » Scientific Advisory Board
 » Dominique Stehelin
Dominique Stehelin
< Back
Dominique Stehelin

Scientific Advisory Board Member

American

Dr. Stehelin is the director of the CHRS unit for the Development and Mechanisms of Cancer at the Pasteur Institute in Lille, France. He is renowned for his work on the molecular basis of cancer and is a member of the Institut de France’s Sciences Academy.

Dr Stehelin has an M.D. and Ph.D. in Medicine and a Ph.D. in Sciences
 

Site map - © 2009 ExonHit Therapeutics. All Rights Reserved - Legal information -